Consideration of Tranexamic Acid Administration to COVID-19 Patients.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
   Review
2. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.International journal of molecular sciences · 2022
   Review
3. Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review.Drug development research · 2022
   Review
4. Druggable targets and therapeutic development for COVID-19.Frontiers in chemistry · 2022
   Review
5. Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: A timing challenge for clinicians.Pulmonary pharmacology & therapeutics · 2021
   Article
6. In silico drug repurposing in COVID-19: A network-based analysis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
   Article
7. Perioperative management of post-COVID-19 surgical patients: Indian Society of Anaesthesiologists (ISA National) Advisory and Position Statement.Indian journal of anaesthesia · 2021
   Article
8. Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
   Review
9. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.International journal of hematology · 2021
   Review
10. Diversity of disseminated intravascular coagulation and selection of appropriate treatments.International journal of hematology · 2021
    Article
11. COVID-19-associated coagulopathy and disseminated intravascular coagulation.International journal of hematology · 2021
    Review
12. Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms.Frontiers in cardiovascular medicine · 2021
    Review
13. COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment.SN comprehensive clinical medicine · 2021
    Review
14. Spontaneous anterior cervicothoracic spinal epidural hematoma extending to clivus in SARS-CoV-2 infection.Surgical neurology international · 2021
    Article
15. Severe Postpartum Hemorrhage in an Asymptomatic COVID-19 Patient: A Call to Be on Guard.International medical case reports journal · 2021
    Article
16. Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article

Corrections and comments

• Comment on
  Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as